NUWE
Nuwellis, Inc.NASDAQHealthcare$1.09+0.00%ClosedMarket Cap: $983,905
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
0.67
P/S
0.12
EV/EBITDA
-0.03
DCF Value
$-0.62
FCF Yield
-1107.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
62.0%
Operating Margin
-134.3%
Net Margin
-211.9%
ROE
-6046.6%
ROA
-286.4%
ROIC
-331.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $2.4M | 68.2% | $-2.4M | $-2.4M | $-1.50 | — |
| FY 2025 | $8.3M | 62.0% | $-11.1M | $-17.5M | $-25.39 | — |
| Q3 2025 | $2.2M | 65.2% | $-2.7M | $468.0K | $0.56 | — |
| Q2 2025 | $1.7M | 55.5% | $-2.9M | $-12.6M | $-60.99 | — |
| Q1 2025 | $1.9M | 56.0% | $-3.1M | $-3.0M | $-0.69 | — |
| Q4 2024 | $2.3M | 64.8% | $-2.4M | $-1.5M | $-0.44 | — |
| FY 2024 | $8.7M | 66.7% | $-11.0M | $-11.2M | $-8.00 | — |
| Q3 2024 | $2.4M | 70.0% | $-1.5M | $2.4M | $73.08 | — |
| Q2 2024 | $2.2M | 67.2% | $-2.3M | $-7.7M | $-18.86 | — |
| Q1 2024 | $1.9M | 64.1% | $-4.7M | $-4.3M | $-21.10 | — |
| Q4 2023 | $2.6M | 54.4% | $-3.6M | $-5.5M | $-54.48 | — |
| FY 2023 | $8.9M | 56.2% | $-17.6M | $-20.2M | $-360.07 | — |